Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMe-STAR
NCT07150806Phase 2Recruiting
- Start
- Nov 2025
- Primary completion
- Dec 2026
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of actinium-225 dotatate in meningioma. Started Nov 2025; status: recruiting.
02
Drugs
actinium-225 dotatate
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT07150806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07150806.